Loading organizations...

§ Private Profile · New York City, NY, USA
3D software platform for interactive human anatomy, disease, and treatment visualization, serving healthcare and medical education.
Based in New York, New York, BioDigital develops a cloud-based interactive 3D software platform for visualizing human anatomy, complex diseases, and medical treatments. The company operates a B2B software-as-a-service model, providing application programming interfaces and embeddable widgets that feature over 8,000 selectable anatomical structures and 600 simulated health conditions. Operating with a dedicated workforce of 66 employees, the enterprise currently serves a global user base of more than 4 million registered professionals, patients, and medical students. BioDigital has secured at least $4 million in Series A funding from lead investor FirstMark Capital, while its technology is utilized by over 5,000 educational institutions and corporate customers, including major entities like Johnson & Johnson and the NYU Grossman School of Medicine. The healthcare technology company was originally founded in 2003 by entrepreneurs Frank Sculli and John Qualter.
BioDigital has raised $4.0M across 1 funding round.
BioDigital has raised $4.0M in total across 1 funding round.
BioDigital has raised $4.0M in total across 1 funding round.
BioDigital's investors include FirstMark Capital, BoxGroup, RRE Ventures, RTP Ventures, Social Starts, Marc Lore, Jim Pallotta, NYU Ventures.
BioDigital is a technology company that develops the BioDigital Human, a cloud-based interactive 3D platform visualizing human anatomy, diseases, and treatments. It serves medical schools, healthcare providers, pharmaceutical and device companies, and patient education by making complex health information accessible and engaging through immersive 3D visualizations available on any device, including AR/VR. The platform addresses the problem of medical complexity and low health literacy, improving understanding, communication, and education in healthcare. BioDigital powers over 100 million health conversations globally each year, demonstrating strong growth and adoption in medical education and clinical workflows[2][4].
Founded by experts in biomedical engineering, 3D medical animation, and health informatics, BioDigital emerged from over 20 years of experience in using 3D technology to explain complex medical concepts. The flagship BioDigital Human platform was launched in 2013, building on a decade of pioneering healthcare visualization tools. The company evolved to include BioDigital XR in 2022, extending its immersive 3D content into virtual and augmented reality. Early traction came from adoption by top medical schools and healthcare organizations seeking to reduce medical errors and improve patient communication[2][5].
BioDigital rides the growing trend of digital health, immersive learning, and personalized medicine by transforming how anatomy and medical conditions are taught and communicated. The timing is critical as healthcare increasingly demands scalable, remote, and interactive educational tools to address workforce training gaps and patient literacy challenges. Market forces such as rising telehealth adoption, AR/VR technology maturation, and the need for precision communication in healthcare favor BioDigital’s platform. By enabling clearer understanding of human biology and treatments, BioDigital influences medical education, patient engagement, and pharmaceutical marketing ecosystems[2][4][5].
Looking ahead, BioDigital is poised to deepen its impact by expanding its XR offerings and integrating more AI-driven personalization and analytics to enhance learning outcomes and clinical decision support. Trends in digital therapeutics, precision medicine, and immersive education will shape its evolution. As healthcare systems globally seek to reduce errors and improve patient outcomes, BioDigital’s role as a foundational visualization and communication tool is likely to grow, potentially becoming a standard in medical training and patient care communication. This aligns with its mission to make health and the human body understandable to all, continuing to transform how we visualize and interact with medical knowledge[2][5].
BioDigital has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in September 2013.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2013 | $4M Series A | FirstMark Capital | BoxGroup, RRE Ventures, RTP Ventures, Social Starts, Marc Lore, JIM Pallotta, NYU Ventures | Announced |